Earnings Call Insights: Achieve Life Sciences (ACHV) Q1 2026 Management View "I'm honored to step into the role of Chief Executive Officer at such an important time." (CEO, President & Director Andrew Goldberg) Goldberg said Achieve is developing cytisinicline for "cessation of smoking" and "vaping," and highlighted leadership and governance changes, including: "We also recently appointed 3 new Bo...
Earnings Call Insights: Achieve Life Sciences (ACHV) Q1 2026 Management View "I'm honored to step into the role of Chief Executive Officer at such an important time." (CEO, President & Director Andrew Goldberg) Goldberg said Achieve is developing cytisinicline for "cessation of smoking" and "vaping," and highlighted leadership and governance changes, including: "We also recently appointed 3 new Board members" and "announced 2 of Chris' prior colleagues from Verona joining us as key leaders in our commercial team, Mark Zappia as Senior Vice President of Commercial; and Jim Willis as Vice President of Sales and Enablement." (CEO Goldberg) "We closed a transformational financing, which positions us for success." (CEO Goldberg) Goldberg said the private placement included "$180 million in upfront capital, plus up to $174 million from milestone-based warrants" tied to FDA approval, and thanked participating investors including "Frazier Life Sciences, TPG, venBio, Paradigm BioCapital, Marshall Wace." (CEO Goldberg) "In mid-April, the company announced it expects to receive a complete response letter from the FDA on or by our June 20 PDUFA date" due to "a separate third-party manufacturer" receiving an "official action indicated" status, adding, "these observations relate to general cGMP matters at the facility and are not specific to cytisinicline manufacturing." (CEO Goldberg) He reiterated: "The company's plan, as previously stated, is to resubmit the NDA in the fourth quarter of 2026" and "The company's stated expectation is for a commercial launch in the first half of 2027." (CEO Goldberg) "In the first quarter, we produced our first cytisinicline engineering batch" at Adare, and management expects the U.S. supply partnership to "help decrease risk related to international importation of pharmaceuticals, including potential tariffs." (CEO Goldberg) "Importantly, among participants with prior varenicline and bupropion use, those receiving 12 weeks of cytisinicline achi...
NVIDIA (NASDAQ:NVDA) stock just earned a fresh endorsement from Wells Fargo, which raised its price target to $315 from $265 and reiterated its Overweight rating on NVIDIA. The price target raise lands just eight days before NVIDIA’s quarterly report on May 20, with the firm arguing the stock still trades at less than 20 times ... Wells Fargo Hikes NVIDIA Price Target to $315 Ahead of Earnings: Is...
NVIDIA (NASDAQ:NVDA) stock just earned a fresh endorsement from Wells Fargo, which raised its price target to $315 from $265 and reiterated its Overweight rating on NVIDIA. The price target raise lands just eight days before NVIDIA’s quarterly report on May 20, with the firm arguing the stock still trades at less than 20 times ... Wells Fargo Hikes NVIDIA Price Target to $315 Ahead of Earnings: Is the AI King Still Cheap at 20x P/E?
Virginia Democrats Ask US Supreme Court To Reinstate Congressional Map Authored by Bryan Hyde via American Greatness, Virginia Democrats, along with their state Attorney General, have asked the US Supreme Court to override the Virginia Supreme Court’s decision last week that struck down a partisan redistricting plan. ABC News reports Virginia Attorney General Jay Jones wrote in the emergency appli...
Virginia Democrats Ask US Supreme Court To Reinstate Congressional Map Authored by Bryan Hyde via American Greatness, Virginia Democrats, along with their state Attorney General, have asked the US Supreme Court to override the Virginia Supreme Court’s decision last week that struck down a partisan redistricting plan. ABC News reports Virginia Attorney General Jay Jones wrote in the emergency application filed on Monday that the Virginia Supreme Court was “deeply mistaken” when it invalidated a ballot measure to amend the state constitution that would have netted Democrats as many as four new congressional seats. The state Supreme Court had ruled last Friday , in a 4–3 decision, that Democrats had violated the state Constitution, by failing to follow proper procedures, while racing to get the measure on the ballot before the midterm elections. According to SCOTUSblog , Virginia’s General Assembly adopted a new map in February that would have favored Democrats in 10 of the state’s 11 seats in the US House—a potential increase of four seats from the current balance between Democrats and Republicans in Virginia. The new map hinged on obtaining approval for an amendment to the Virginia constitution that would give the state legislature the power to draw a new congressional map outside of the normal cycle following the decennial census. In a referendum held in April, Virginia voters approved that amendment by a margin of three percentage points . The Virginia Supreme Court ruled that the referendum was not valid because the General Assembly had not followed proper procedures when it put the new amendment on the ballot. In Monday’s 24-page filing, Jones argued: “ The irreparable harm resulting from the Supreme Court of Virginia’s decision is profound and immediate . By forcing the Commonwealth to conduct its congressional elections using districts different from those adopted by the General Assembly pursuant to a constitutional amendment the people just ratified, the Supre...
On the May 8 episode of CNBC’s Halftime Report, the panel openly questioned whether the AI-driven rally has stopped discriminating between core AI plays and merely AI-adjacent names. One of the cleanest examples is Qualcomm (NASDAQ:QCOM), where the stock gained around 70% in a month despite posting merely decent results and guiding lower for the ... AI Rally May Have Gone Too Far With Some Stocks ...
On the May 8 episode of CNBC’s Halftime Report, the panel openly questioned whether the AI-driven rally has stopped discriminating between core AI plays and merely AI-adjacent names. One of the cleanest examples is Qualcomm (NASDAQ:QCOM), where the stock gained around 70% in a month despite posting merely decent results and guiding lower for the ... AI Rally May Have Gone Too Far With Some Stocks Up 70% in a Month
Mizuho just turned more bullish on Advanced Micro Devices (NASDAQ:AMD), raising its price target to $515 from $415 while keeping an Outperform rating. The firm cited agentic AI continuing to drive server demand as the catalyst behind the call. The price target raise is a sign that Wall Street views AMD as a primary beneficiary ... Mizuho Just Hiked AMD Price Target to $515: Agentic AI Server Deman...
Mizuho just turned more bullish on Advanced Micro Devices (NASDAQ:AMD), raising its price target to $515 from $415 while keeping an Outperform rating. The firm cited agentic AI continuing to drive server demand as the catalyst behind the call. The price target raise is a sign that Wall Street views AMD as a primary beneficiary ... Mizuho Just Hiked AMD Price Target to $515: Agentic AI Server Demand Powers the Bull Case